Intelligent Bio Solutions
(NASDAQ) GBS
Intelligent Bio Solutions Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$3.58M
Net Income (TTM)
$11.29M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
GBS News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Intelligent Bio Solutions
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
55
CEO
Harry Simeonidis
Website
ibs.incHeadquarters
New York City, NY 10019, US
GBS Financials
Key Financial Metrics (TTM)
Gross Margin
30%
Operating Margin
-3%
Net Income Margin
-3%
Return on Equity
-2%
Return on Capital
-90%
Return on Assets
-64%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$1.25M
Operating Income
$10.64M
EBITDA
$11.85M
Operating Cash Flow
$9.68M
Capital Expenditure
$231.84K
Free Cash Flow
$9.91M
Cash & ST Invst.
$1.02M
Total Debt
$281.81K
Intelligent Bio Solutions Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$896.77K
+47.6%
Gross Profit
$459.74K
+106.1%
Gross Margin
51.27%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
12
N/A
Net Income
$2.68M
-19.0%
EBITDA
$2.92M
-13.5%
Quarterly Fundamentals
Net Cash
$1.18M
-173.3%
Accounts Receivable
$456.66K
+71.6%
Inventory
$590.25K
-15.8%
Long Term Debt
$1.53M
+10419.9%
Short Term Debt
$395.52K
-35.3%
Return on Assets
-63.98%
N/A
Return on Invested Capital
-89.96%
N/A
Free Cash Flow
$1.64M
+29.6%
Operating Cash Flow
$1.57M
+32.6%